CVS Health Corp (CVS) – Mismatched value: Check Out the Fundamental Analysis

In Tuesday’s Wall Street session, CVS Health Corp (NYSE:CVS) shares traded at $65.03, up 0.15% from the previous session.

CVS stock price is now -1.91% away from the 50-day moving average and 10.27% away from the 200-day moving average. The market capitalization of the company currently stands at $82.09B.

With the price target enhanced from $55 to $75, Leerink Partners Upgraded its rating from Market Perform to Outperform for CVS Health Corp (NYSE: CVS). , while ‘Edward Jones’ rates the stock as ‘Buy’

In other news, Clark James David, SVP, Cont & Chief Acct Officer sold 7,513 shares of the company’s stock on Mar 05 ’25. The stock was sold for $498,488 at an average price of $66.35. Upon completion of the transaction, the SVP, Cont & Chief Acct Officer now directly owns 8,394 shares in the company, valued at $0.55 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 05 ’25, Officer Clark James David bought 7,513 shares of the business’s stock. A total of $498,489 was incurred on buying the stock at an average price of $66.35. A total of 0.14% of the company’s stock is owned by insiders.

During the past 12 months, CVS Health Corp has had a low of $43.56 and a high of $71.45. As of last week, the company has a debt-to-equity ratio of 1.10, a current ratio of 0.81, and a quick ratio of 0.60. According to the stock market information, the enterprise value for the company is $154086506496, which is based on a 17.78 price-to-earnings ratio, a 1.31 price-to-earnings-growth ratio, and a beta of 0.60. The fifty day moving average price for CVS is $66.2932 and a two-hundred day moving average price translates $58.9713 for the stock.

The latest earnings results from CVS Health Corp (NYSE: CVS) was released for 2024-12-31. The net profit margin was 1.24% and return on equity was 6.07% for CVS. The company reported revenue of $97.71 billion for the quarter, compared to $93.81 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 4.15 percent.

Related Posts

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.